Last News

Besides following our news, follow us on socials networks :

TransCure’s interview in the ECO Savoie Mont-Blanc (in french) 12 June 2019

What services TransCure bioServices is offering? Who are its clients? What are its achievements? What are its news goals and new challenges with its recent funding of 2.5 million euros? Get the answers in the ECO article. (article n french).

Read more

New financing round will enable the company to accelerate its growth and expand its international services offers.

Read more
Champions Oncology, Inc. (NASDAQ: CSBR) signs a strategic partnership with TransCure bioServices SAS 31 May 2019

Strategic partnership with Champions Oncology, Inc

Read more
TransCure’s proposal for Horizon 2020 has been selected by the European Research & Innovation funding program 22 May 2019

TransCure bioServices SAS was selected for the SME instruments call-to-offer Phase 1 with 273 companies out of 2’822 applicants.

Read more
Adrien MOSSU, new Deputy Project Officer, has been hired by TransCure bioServices 23 April 2019

TransCure bioServices hires Adrien MOSSU – New Deputy Project Officer

Read more
TransCure bioServices involved in INSERM results 11 April 2019

INSERM publishes first in vivo proof of concept of an engineered Chimeric Antigen Receptor T cell directed against IL-1RAP expressed by leukemia stem cells using TransCure’s full human immune system hu-mouse models.

Read more